MICHAEL T. CULLEN

Profile

First Name

: MICHAEL

Middle Name

: T.

Last Name

: CULLEN

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
SUN BIOPHARMA, INC.
SUZANNE GAGNON, RYAN R. GILBERTSON, JEFFREY R. HARDER, PAUL M. HERRON, CHRISTOPHER R. JOHNSON, RANDALL L. JOHNSON, DAVID B. KAYSEN, CLIFFORD F. MCCURDY, III, THOMAS X. NEENAN, DOUGLAS M. POLINSKY, DANIEL E. RYWECK, PAUL W. SCHAFFER, D. ROBERT SCHEMEL, DONALD R. SCHEMEL
EXECUTIVE OFFICER, DIRECTOR
SUN BIOPHARMA RESEARCH, INC.
SUZANNE GAGNON, RYAN R. GILBERTSON, JEFFREY R. HARDER, PAUL M. HERRON, CHRISTOPHER R. JOHNSON, RANDALL L. JOHNSON, DAVID B. KAYSEN, CLIFFORD F. MCCURDY, III, THOMAS X. NEENAN, DOUGLAS M. POLINSKY, DANIEL E. RYWECK, PAUL W. SCHAFFER, D. ROBERT SCHEMEL, DONALD R. SCHEMEL
DIRECTOR, EXECUTIVE OFFICER
SUN BIOPHARMA, INC.
MICHAEL T CULLEN, DANIEL DONOVAN, ARTHUR J. FRATAMICO, SUZANNE GAGNON, DALVIR S GILL, DALVIR S. GILL, SUSAN HORVATH, SUSAN M. HORVATH, JEFFREY E. JACOB, DAVID B KAYSEN, DAVID B. KAYSEN, SCOTT KELLEN, JEFFREY S MATHIESEN, JEFFREY S. MATHIESEN, J. ROBERT PAULSON, J. ROBERT PAULSON, JR., PAUL W SCHAFFER, PAUL W. SCHAFFER, D. ROBERT SCHEMEL, ROBERT SCHEMEL, ROBERT D. SCHEMEL, JENNIFER K. SIMPSON
DIRECTOR, EXECUTIVE OFFICER
PANBELA THERAPEUTICS, INC.
MICHAEL T CULLEN, DANIEL DONOVAN, ARTHUR J. FRATAMICO, SUZANNE GAGNON, DALVIR S GILL, DALVIR S. GILL, SUSAN HORVATH, SUSAN M. HORVATH, JEFFREY E. JACOB, DAVID B KAYSEN, DAVID B. KAYSEN, SCOTT KELLEN, JEFFREY S MATHIESEN, JEFFREY S. MATHIESEN, J. ROBERT PAULSON, J. ROBERT PAULSON, JR., PAUL W SCHAFFER, PAUL W. SCHAFFER, D. ROBERT SCHEMEL, ROBERT SCHEMEL, ROBERT D. SCHEMEL, JENNIFER K. SIMPSON
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-01-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-12-21 
2023-11-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-11-02 
2022-06-29
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-06-15 
2019-09-09
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-08-23 
2019-01-04
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2018-12-21 
2018-03-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-02-20 
2016-06-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-06-10 
2015-09-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-04 
2014-02-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-01-24 
2013-06-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-05-08 
2013-05-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-05-08 
2012-03-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-25